Launxp Biomedical Co (ROCO:6876) Total Assets: NT$403.03 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6876 Launxp Biomedical Co Ltd ROCO:6876
11 GF Score
Price NT$16.00
! 4 Warning Signs
View Full Analysis

What is Launxp Biomedical Co Total Assets?

Launxp Biomedical Co ROCO:6876 -0.62% 11 Total Assets is NT$403.03 Mil as of Dec. 2025. GuruFocus rates ROCO:6876 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

Launxp Biomedical Co's Total Assets for the quarter that ended in Dec. 2025 was NT$403.03 Mil.

During the past 12 months, Launxp Biomedical Co's average Total Assets Growth Rate was 1282.10% per year. During the past 3 years, the average Total Assets Growth Rate was 173.60% per year. During the past 5 years, the average Total Assets Growth Rate was 85.00% per year.

During the past 6 years, Launxp Biomedical Co's highest 3-Year average Total Assets Growth Rate was 173.60%. The lowest was 26.00%. And the median was 50.20%.

Total Assets is connected with ROA %. Launxp Biomedical Co's annualized ROA % for the quarter that ended in Dec. 2025 was -23.34%. Total Assets is also linked to Revenue through Asset Turnover. Launxp Biomedical Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Launxp Biomedical Co  (ROCO:6876) Total Assets Explanation

Total Assets is connected with ROA %.

Launxp Biomedical Co's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-113.34/( (568.229+403.034)/ 2 )
=-113.34/485.6315
=-23.34 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Launxp Biomedical Co's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (568.229+403.034)/ 2 )
=0/485.6315
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Launxp Biomedical Co Total Assets Related Terms

Launxp Biomedical Co Total Assets Historical Data

* Premium members only.

The historical data trend for Launxp Biomedical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Launxp Biomedical Co Total Assets Chart

Launxp Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 73.88 32.44 206.49 123.91 403.03

Launxp Biomedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 206.49 161.89 123.91 568.23 403.03
ROCO:6876
11GF Score
Launxp Biomedical Co Ltd ROCO:6876
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Launxp Biomedical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Launxp Biomedical Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=251.65+151.384
=403.03

Launxp Biomedical Co's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=251.65+151.384
=403.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of NT$403.03 Mil mean?
Launxp Biomedical Co (ROCO:6876) has a Total Assets of NT$403.03 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Launxp Biomedical Co and its competitors.
Is Launxp Biomedical Co's Total Assets too high?
Launxp Biomedical Co's current Total Assets is NT$403.03 Mil. Overall, Launxp Biomedical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Launxp Biomedical Co's Total Assets compare to VRTX and REGN?
Launxp Biomedical Co's Total Assets of NT$403.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Launxp Biomedical Co and its competitors. Launxp Biomedical Co's current Total Assets is NT$403.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Launxp Biomedical Co stock overvalued right now?
Launxp Biomedical Co (ROCO:6876) has a current Total Assets of NT$403.03 Mil. The current Total Assets is NT$403.03 Mil. Launxp Biomedical Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Launxp Biomedical Co (ROCO:6876), the current Total Assets is NT$403.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Launxp Biomedical Co Business Description

Address 10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.
11GF Score

Get the complete analysis for ROCO:6876

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.00
Price